Updated: Jul 22
Well, Genentech just released their quarterly fatalities report on Emicizumab (Hemlibra) and we are now up to 17. This is 4 more than last quarter.
Again, they give no detailed information surrounding these fatalities. It’s safe to assume that the number will be higher next quarter as it keeps going up every time they release a new report.
Anyone want to place their bets and guess what the number will be next quarter?
It’s been a rocky year for Genentech and we have been on them since January. Genentech has issued numerous fatalitie reports, sent out the wrong gauge needles in patients orders and failed to timely notify patients of translucent particles found in vials of Hemlibra.
We will see you in Q4 with the next update.